Unlike small-molecule drugs, biologics manufacturing cannot be simply scaled up on demand because "the process is the product." A superior manufacturing and supply chain capability is not a back-office function but a key market differentiator that commercial teams must leverage to win customers and outpace competitors.
Ger Brophy argues the popular "servant leadership" model is flawed. He has witnessed it enable leaders to avoid making difficult choices and then blame their teams for the resulting failures. He advocates for a more direct approach: leaders must lead, take accountability, and own the consequences of their decisions.
To foster deep motivation, leaders must explicitly connect every employee's role, no matter how small, to the ultimate mission. Ger Brophy explains how showing a factory worker that the product they make is critical for a specific cancer treatment allows them to feel personal ownership of the patient impact.
Thriving life sciences ecosystems in Ireland, the UK, and Massachusetts did not grow by accident. Their success is the result of deliberate, long-term government strategies, including tax incentives, shared R&D infrastructure like the UK's 'Catapult' network, and fostering deep connections between technology, hospitals, and capital.
Instead of just preaching integrity, leaders must actively design systems that don't reward employees for achieving goals unethically. Character is what someone does when no one is looking, so a leader's role is to structure the environment to prevent integrity breaches before they happen, rather than just reacting to them.
Early career advice focuses on fixing weaknesses. However, experienced leaders should shift their focus. While weaknesses must be mitigated so they don't become a liability, true effectiveness comes from understanding, amplifying, and deploying your core strengths, which is what ultimately makes you a great leader.